\n\n\n\n\t\t\n\t\t\tPortola Pharmaceuticals\n\t\t\thttp://www.portola.com/\n\t\t
\n\t\t\n\t\t\tWatch Company\n\t\t\tGet Widget\n\t\t
\n\tPortola is dedicated to the discovery, development and commercialization of novel therapeutics for the prevention and treatment of cardiovascular disease. Portola has a highly experienced team focused...More»
\n\t\t\tPortola is dedicated to the discovery, development and commercialization of novel therapeutics for the prevention and treatment of cardiovascular disease. Portola has a highly experienced team focused in the areas of vascular thrombosis and inflammation. The company believes that its integrated approach to discovery, development and commercialization, applied to its comprehensive understanding of platelet physiology and vascular thrombosis will result in new therapeutics where current therapies are inadequate. Portola\'s investors include Sutter Hill Ventures, Prospect Ventures, MPM Capital, Abingworth Management and Frazier Healthcare Ventures.«Less
\n\n\t\t\tOverview
\n\t\t\t\tLocation: \tSouth San Francisco, CA, United States\n
\n\t\t\t\tIndustry: Biopharmaceuticals
\n\t\t\t\tTags:\n\t\t\t\tbiotech,\n\t\t\t\tpharmaceuticals,\n\t\t\t\ttherapeutics,\n\t\t\t\tportoloa,\n\t\t\t\tcardiovascular\n\t\t\t\t
\n\t\t\tFinancials
\n\t\t\t\tLatest Funding: Series D - $60M (07/2008)
\n\t\t\t\tInvestors:\n\t\t\t\t\t\n\t\tD.E. Shaw Group,\n\t\t\t\t\t\n\t\tAdage Capital Management,\n\t\t\t\t\t\n\t\tBBT Capital Management/Apothecary Capital,\n\t\t\t\t\t\n\t\tJanus Capital Group,\n\t\t\t\t\t\n\t\tPac-Link BioVentures\n\t\t\t\t
\n\t\t\tMarket
\n\n\t\t\t\tRelated Companies:\n\t\t\t\t\tHyperion Therapeutics,\n\t\t\t\t\tSequel Pharmaceuticals,\n\t\t\t\t\tCytokinetics,\n\t\t\t\t\tArete Therapeutics,\n\t\t\t\t\tProteus Biomedical,\n\t\t\t\t\tEsperion Therapeutics,\n\t\t\t\t\tNereus Pharmaceuticals,\n\t\t\t\t\tDirect Therapeutics,\n\t\t\t\t\tPresidio Pharmaceuticals,\n\t\t\t\t\tBioMarker Pharmaceuticals\n\t\t\t\t
\n\t\t\tRecent News
\n\t\t\t\t\n\t\t\t\t\tJul 10, 2008\n\t\t\t\t\tPortola Pharmaceuticals Lands $60M\n\t\t\t\t
\n\t\t\t